Join the Leading Global Eye Health Alliance.
MembershipThe World Health Organization (WHO) has officially validated Libya for eliminating trachoma as a public health problem. Libya is now the 28th country globally and the 8th in the Eastern Mediterranean Region to reach this milestone, safeguarding millions from the world’s leading infectious cause of blindness.
A Triumph of Resilience
Libya’s success is a testament to sustained commitment despite a decade of political instability and humanitarian challenges. While control efforts began in the 1970s, the final push launched in 2017 under the National Prevention of Blindness Programme.
This achievement was driven by a powerful coalition including the Libyan Ministry of Health, WHO, and IAPB members Sightsavers, the International Trachoma Initiative (ITI), and Tropical Data.
The Road to Validation
The elimination was secured through rigorous, evidence-based interventions:
“This validation reinforces our conviction that progress against neglected tropical diseases is possible everywhere.” — Dr Tedros Adhanom Ghebreyesus, WHO Director-General
Global Implications
Trachoma remains a threat in approximately 30 countries, putting over 100 million people at risk of blindness. Libya’s success provides a blueprint for the WHO 2021–2030 NTD roadmap, proving that integrated surveillance and international solidarity can overcome even the most complex barriers to eye health.
Reference: World Health Organization. (2026, February 18). WHO validates elimination of trachoma as a public health problem in Libya. Retrieved March 1, 2026, from WHO Eastern Mediterranean Region news releases.
Prevent Blindness is declaring February as Age-related Macular Degeneration (AMD) and Low Vision Month in an effort to provide education and various expert-approved resources to the public and professionals. This year’s AMD and Low Vision Month is generously supported by Gold Sponsor EyePoint, Inc.
According to Johns Hopkins Medicine, AMD is the most common cause of severe loss of eyesight among people 50 and older. And, about 4 million Americans live with low vision, which is defined as chronic visual impairment that cannot be corrected with glasses, contact lenses or medical treatments.
AMD affects the central part of the retina called the “macula.” When AMD damages the macula, the center part of a person’s vision may become blurred or wavy, and a blind spot may develop. Early detection and treatment of AMD is key to helping to prevent significant vision loss.
Two types of AMD include:
“As our population ages, the number of individuals impacted by AMD continues to grow. Many will face difficulties doing the things we sometimes take for granted, such as reading, seeing faces, and driving,” said Jeff Todd, president and CEO of Prevent Blindness. “Our robust collection of resources on AMD and low vision are intentionally created to help minimize vision loss and maintain independence for those impacted by AMD while providing effective tools to the public and providers on ways to save sight.”
As part of AMD and Low Vision Month, Prevent Blindness offers the free AMD GuideMe app. This resource provides a customized overview of AMD along with a tailored resource list and suggested steps to help save sight from the eye disease specific to the individual using the GuideMe app. Prevent Blindness offers additional educational resources including fact sheets and shareable social media graphics in English and Spanish, and dedicated webpages.
New this year, as part of the Prevent Blindness ASPECT Patient Engagement Program Member Spotlight Series, graduate Laurie S., shares her experience with AMD, including her family history with the eye disease, how it impacts her daily activities including the ability to read music, and the importance of support groups “Age-related Macular Degeneration: Laurie’s Story.”
Videos in the Prevent Blindness Focus on Eye Health Series include:
The Prevent Blindness “Living Well With Low Vision” program provides useful information to those with low vision, their care partners and healthcare professionals. Content includes self-help guides, resources for vision loss and mental wellness, information on clinical trials, and much more. Living Well With Low Vision is supported by grants from Amgen and Genentech.
For more information on AMD, please visit PreventBlindness.org/amd. For information on geographic atrophy, please visit PreventBlindness.org/geographic-atrophy.
And, for more information on Living Well With Low Vision, or other general eye health information, please visit lowvision.PreventBlindness.org.
For a listing of organizations and services that provide financial assistance for vision care in English or Spanish, please visit https://preventblindness.org/vision-care-financial-assistance-information.